newsfilter
← Latest News
GlobeNewswire·

BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update

-Merger agreement executed between BridgeBio and Eidos Therapeutics; Potential to bring BridgeBio’s clinical and commercial development infrastructure to bear upon Eidos’ Acoramidis -New Drug...